Dudding B A, Top F H, Scott R M, Russell P K, Buescher E L
Am J Epidemiol. 1972 Feb;95(2):140-7. doi: 10.1093/oxfordjournals.aje.a121378.
Dudding, B. A., F. H. Top, Jr., R. M. Scott, P. K. Russell and E. L. Buescher (Walter Reed Army Institute of Research, Washington, D. C. 20012). An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. 95: 140–147, 1972.—Among 911 recruits immunized with live, oral adenovirus types 4 and 7 (ADV-4 and 7) vaccines, there were 149 hospital admissions to the acute respiratory disease (ARD) wards during the study. Eighteen admissions were not associated with ARD (15 rubella infections, 3 immunization reactions). Of the remaining 131 ARD admissions, 17 were complicated by pneumonia and 114 were judged to have uncomplicated ARD. Within the latter group, evidence for infection by a single respiratory pathogen was obtained from 68 admissions; 11 admissions were associated with multiple infectious agents; and 35 admissions yielded no infectious agent(s). Despite immunization, adenoviruses, primarily ADV-4, were still the most common cause of ARD. Among non-adenovirus associated ARD admissions, rhinoviruses were the most common (10), followed by influenza A2 virus (7), group A streptococci (2) and herpesvirus hominis (2). Thus, in this initial study of ARD among recruits immunized with ADV-4 and ADV-7 vaccines, no other respiratory pathogens emerged to replace adenovirus types 4 and 7 as the major causes of ARD in military trainees.
达丁,B.A.,小F.H.托普,R.M.斯科特,P.K.拉塞尔和E.L.比舍尔(华盛顿特区沃尔特·里德陆军研究所,邮编20012)。对接种4型和7型腺病毒疫苗新兵急性呼吸道疾病住院情况的分析。《美国流行病学杂志》95: 140 - 147,1972年。——在911名接种了4型和7型口服活腺病毒(ADV - 4和ADV - 7)疫苗的新兵中,研究期间有149人因急性呼吸道疾病(ARD)住进病房。18例住院与ARD无关(15例风疹感染,3例免疫反应)。在其余131例ARD住院病例中,17例并发肺炎,114例被判定为单纯性ARD。在后者中,从68例住院病例中获得了单一呼吸道病原体感染的证据;11例与多种感染因子有关;35例未检出感染因子。尽管接种了疫苗,但腺病毒,主要是ADV - 4,仍然是ARD最常见的病因。在与腺病毒无关的ARD住院病例中,鼻病毒最常见(10例),其次是甲型流感病毒A2(7例)、A组链球菌(2例)和人疱疹病毒(2例)。因此,在这项对接种ADV - 4和ADV - 7疫苗新兵的ARD初步研究中,没有其他呼吸道病原体取代4型和7型腺病毒成为军事受训人员ARD的主要病因。